ADICON HOLDINGS (09860) surged over 5% once more, accumulating a gain of 20% over the past three trading sessions. At the time of writing, the stock was up 5.68%, trading at HK$5.4, with a turnover of HK$17.98 million.

Positive catalysts in the AI medical field have been frequent recently. Nvidia and the American pharmaceutical giant Eli Lilly announced on Monday local time that they will jointly invest $1 billion over the next five years to establish a joint research laboratory in the San Francisco Bay Area, aimed at accelerating the application of artificial intelligence (AI) in the pharmaceutical industry. Furthermore, OpenAI announced on the social media platform X on Monday that it has acquired the medical technology startup Torch. Notably, the application of AI in healthcare within China is also showing an accelerating development trend; Ant Group's AI medical product, Afu, has surpassed 15 million monthly active users, while major internet players like ByteDance, Baidu, JD.com, and Tencent have successively made their moves. It is reported that in December 2025, ADICON formally signed a cooperation agreement with Huawei Cloud, marking a new stage of collaborative innovation in the smart healthcare sector for both parties. The collaboration between ADICON and Huawei Cloud has jointly initiated a new chapter in smart healthcare powered by AI technology. This partnership represents not only a deep integration of technological capabilities and industry scenarios but also a significant milestone in the evolution of medical testing services from traditional models towards intelligent and ecosystem-driven approaches.